Analysis of lymphocyte composition of the intestinal tract and peripheral blood in patients treated with immune checkpoint inhibitors

Analysis of lymphocyte composition of the intestinal tract and peripheral blood in patients treated with immune checkpoint inhibitors - Analysis of lymphocytes in patients treated with immune checkpoint inhibitors

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043268

Enrollment

Registered

2021-02-08

Start date

2021-02-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients treated with immune checkpoint inhibitors

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients treated with immune checkpoint inhibitors

Exclusion criteria

Exclusion criteria: Pregnant patients

Design outcomes

Primary

Measure	Time frame
lymphocyte composition of the intestinal tract and peripheral blood in patients treated with immune checkpoint inhibitors	—

Countries

Japan

Contacts

Public ContactMasaya Iwamuro

Okayama University Hospital Department of Gastroenterology and Hepatology

iwamuromasaya@yahoo.co.jp0862357218

Outcome results